Circassia Group plc
Director/PDMR Shareholding
Oxford, UK - 17 September 2021: Circassia Group plc ("Circassia" or "the Company") (LSE: CIR), a medical device company focused on point of care asthma diagnosis and management, today announces that on 16 September 2021, Ian Johnson, Executive Chairman, purchased 150,000 Ordinary Shares at a price of 37.10 pence per share, Michael Roller, Chief Financial Officer purchased 125,000 Ordinary Shares at a price of 37.10 pence per share and Jonathan Emms, Chief Operating Officer, purchased 26,921 Ordinary Shares at a price of 37.10 pence per share.
Following these purchases, Ian Johnson holds 550,000 Ordinary Shares (0.13% of the issued share capital of the Company), Michael Roller holds 500,000 Ordinary Shares (0.12% of the issued share capital of the Company) and Jonathan Emms holds 694,849 Ordinary Shares (0.17% of the issued share capital of the Company).
Additional detail is provided below in accordance with the requirements of UK MAR.
Contacts
Circassia Ian Johnson, Executive Chairman Michael Roller, Chief Financial Officer Sarah Duncan, Company Secretary
| Tel: +44(0)1865 405566 |
Singer Capital Markets (Nominated Adviser and Broker) Aubrey Powell / Jen Boorer / Hannah Woodley | Tel: +44 (0) 20 7496 3000 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
a. | Name | (1) Ian Johnson (2) Michael Roller (3) Jonathan Emms | ||||
2. | Reason for the notification | |||||
a. | Position/status | (1) Executive Chairman (2) Chief Financial Officer (3) Chief Operating Officer | ||||
b. | Initial notification/Amendment
| Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a. | Name | Circassia Group plc | ||||
b. | LEI | 2138006YAT138TOGA556 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary Shares of 0.08p each
GB00BJVD3B28 | ||||
b. | Nature of the transaction | Purchase of Ordinary Shares | ||||
c. | Price(s) and volume(s) |
| ||||
d. | Aggregated information · Aggregated volume · Price
|
| ||||
e. | Date of the transaction | 16/09/2021 | ||||
f. | Place of the transaction | London Stock Exchange, AIM |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.